Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 2
2006 2
2007 5
2008 19
2009 9
2010 11
2011 6
2012 8
2013 6
2014 4
2015 6
2016 2
2017 2
2018 2
2019 2
2020 4
2021 10
2022 6
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

93 results

Results by year

Filters applied: . Clear all
Page 1
Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial.
Boorjian SA, Alemozaffar M, Konety BR, Shore ND, Gomella LG, Kamat AM, Bivalacqua TJ, Montgomery JS, Lerner SP, Busby JE, Poch M, Crispen PL, Steinberg GD, Schuckman AK, Downs TM, Svatek RS, Mashni J Jr, Lane BR, Guzzo TJ, Bratslavsky G, Karsh LI, Woods ME, Brown G, Canter D, Luchey A, Lotan Y, Krupski T, Inman BA, Williams MB, Cookson MS, Keegan KA, Andriole GL Jr, Sankin AI, Boyd A, O'Donnell MA, Sawutz D, Philipson R, Coll R, Narayan VM, Treasure FP, Yla-Herttuala S, Parker NR, Dinney CPN. Boorjian SA, et al. Among authors: crispen pl. Lancet Oncol. 2021 Jan;22(1):107-117. doi: 10.1016/S1470-2045(20)30540-4. Epub 2020 Nov 27. Lancet Oncol. 2021. PMID: 33253641 Free PMC article. Clinical Trial.
Editorial Comment.
O'Malley P, Crispen PL. O'Malley P, et al. Among authors: crispen pl. J Urol. 2023 Jan;209(1):47-48. doi: 10.1097/JU.0000000000002957.01. Epub 2022 Oct 10. J Urol. 2023. PMID: 36215689 No abstract available.
Editorial comment.
Crispen PL. Crispen PL. Urology. 2013 May;81(5):997; discussion 997. doi: 10.1016/j.urology.2012.10.081. Epub 2013 Feb 28. Urology. 2013. PMID: 23453655 No abstract available.
Editorial comment.
Crispen PL, Blute ML. Crispen PL, et al. Urology. 2009 Nov;74(5):1046; author reply 1046-7. doi: 10.1016/j.urology.2009.05.081. Urology. 2009. PMID: 19883819 No abstract available.
Editorial Commentary.
Crispen PL. Crispen PL. Urol Pract. 2016 Nov;3(6):436. doi: 10.1016/j.urpr.2015.10.015. Epub 2016 Jul 21. Urol Pract. 2016. PMID: 37592595 No abstract available.
Hyaluronan Metabolism in Urologic Cancers.
Donelan W, Brisbane W, O'Malley P, Crispen P, Kusmartsev S. Donelan W, et al. Among authors: crispen p. Adv Biol (Weinh). 2023 Dec;7(12):e2300168. doi: 10.1002/adbi.202300168. Epub 2023 Aug 24. Adv Biol (Weinh). 2023. PMID: 37615259 Review.
Lymph Node Dissection for Small Renal Masses.
Blute ML Jr, Gupta M, Crispen PL. Blute ML Jr, et al. Among authors: crispen pl. Urol Clin North Am. 2017 May;44(2):269-274. doi: 10.1016/j.ucl.2016.12.012. Epub 2017 Mar 14. Urol Clin North Am. 2017. PMID: 28411918 Review.
Mechanisms of immune evasion in bladder cancer.
Crispen PL, Kusmartsev S. Crispen PL, et al. Cancer Immunol Immunother. 2020 Jan;69(1):3-14. doi: 10.1007/s00262-019-02443-4. Epub 2019 Dec 6. Cancer Immunol Immunother. 2020. PMID: 31811337 Free PMC article. Review.
93 results